Literature DB >> 30239119

Development and Preliminary Validation of a Depression Assessment Tool for Maintenance Hemodialysis Patients.

Yun-Yan Wang1, Wei-Wei Zhang1, Lei Feng1, Dong Gao2, Chun Liu3, Ling Zhong4, Jiang-Wen Ren5, Ya-Zhou Wu6, Long Huang1, Li-Li Fu1, Ya-Ni He1.   

Abstract

Patients undergoing maintenance hemodialysis (MHD) are subject to a higher-than-usual prevalence of depressive disorders. However, the lack of consensus regarding the best assessment method remains an important problem. Thus, there is a clear need for more effective screening tools and an easily administered, disease-specific self-report measure of depression in MHD patients. After we developed and administered an initial depression inventory for MHD patients (I-DI-MHD), we created the DI-MHD and administered the DI-MHD and the Beck Depression Inventory (BDI) to 354 patients from four hospitals. Reliability, construct validity and receiver operator characteristic curves were assessed. The 17-item DI-MHD instrument displayed good internal consistency (Cronbach's alpha =0.893), provided excellent convergent validity, and correlated with the BDI scale (kappa =0.785, P <0.001). A factor analysis pattern matrix analysis showed that a four-factor model provided the best account of the data. Finally, the DI-MHD cutoff yielded a sensitivity of 0.97 and a specificity of 0.86, which were slightly better than the corresponding values for the BDI. The DI-MHD scale shows reasonable validity and reliability for assessing depression in MHD patients.
© 2018 International Society for Apheresis, Japanese Society for Apheresis, and Japanese Society for Dialysis Therapy.

Entities:  

Keywords:  Beck Depression Inventory; Depression; Maintenance hemodialysis; Screening instrument

Mesh:

Year:  2018        PMID: 30239119     DOI: 10.1111/1744-9987.12749

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN: 1744-9979            Impact factor:   1.762


  1 in total

1.  Depression Screening Tools for Patients with Kidney Failure: A Systematic Review.

Authors:  Karli Kondo; Jennifer R Antick; Chelsea K Ayers; Devan Kansagara; Pavan Chopra
Journal:  Clin J Am Soc Nephrol       Date:  2020-11-17       Impact factor: 8.237

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.